FINCH THERAPEUTCS GRP (FNCH) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 11 192 sessions, March 21, 2025 to March 23, 2026
- Largest daily move
- -39.2% close of March 23, 2026
- 1-year change
- -47.9% closing prices, March 21, 2025 to March 23, 2026
- 1-month change
- -43.4% closing prices, February 23, 2026 to March 23, 2026
Company Description
FINCH THERAPEUTCS GRP (OTC: FNCH) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $11.7M.
FNCH has declined 47.9% over the past year. The last closing price was $7.30.
For FY2023, FINCH THERAPEUTCS GRP reported revenue of $107K with net income of -$74.8M and diluted earnings per share of -$46.59.
This page collects what Stock Titan holds for FNCH, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
FINCH THERAPEUTCS GRP (FNCH) closed at $7.30 on March 23, 2026. Over the past 12 months, the price has lost 47.9%.
FNCH Metrics & Rankings
Price returns through March 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
FINCH THERAPEUTCS GRP has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include stock split, earnings, management, clinical trial, conferences. View all FNCH news →
SEC Filings
Financial Highlights
FINCH THERAPEUTCS GRP generated $107K in revenue in FY2023, operating income reached -$83.9M, and net income was -$74.8M. Diluted earnings per share stood at -$46.59. The company generated -$31.5M in operating cash flow. The current ratio was 6.33, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in FINCH THERAPEUTCS GRP (FNCH) currently stands at 38 shares, down 5.0% from the previous reporting period, representing 0.0% of the float. Since October 2025, short interest has decreased by 90.4%.
Days to Cover History
Days to cover for FINCH THERAPEUTCS GRP (FNCH) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
FNCH Company Profile & Sector Positioning
FINCH THERAPEUTCS GRP (FNCH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing FNCH often look at related companies in the same sector, including ONCOTELIC THERAPEUTCS INC (OTLC), RESVERLOGIX CORP (RVXCF), INSTITUTE OF BIOMED RESH (MRES), ACCUSTEM SCIENCES INC (ACUT), and CELL SOURCE INC (CLCS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FNCH's relative position within its industry.